FareVet and Perfect Paw Want to Give Vets Patient Data Before the Visit Starts

FareVet, the veterinary price comparison platform, is integrating Perfect Paw's AI-powered canine wearable into its clinic network. The partnership creates a data pipeline between a consumer health monitor and veterinary practices, giving clinicians access to continuous pain and behavior data before a dog walks through the door. Both companies are early-stage, but the model they're building points to a structural shift in how veterinary intake works.

What Happened

FareVet and Perfect Paw announced the integration on February 20. Under the partnership, veterinarians in FareVet's network can access data from Perfect Paw's wearable device, The Ruff, ahead of appointments. The Ruff is a multi-sensor collar that tracks movement patterns, behavioral changes, and physiological markers, then uses an AI engine to translate that biometric data into pain and wellness assessments.

The integration targets a specific gap in veterinary care: first-time visits. When a dog sees a new vet, whether after an adoption, a move, or a clinic switch, the clinician typically starts with zero patient history. Traditional intake relies on owner observations and a single in-clinic exam. Perfect Paw's pitch is that continuous monitoring catches what episodic visits miss.

"Pain detection only creates impact when it reaches the people who can act on it," said Rhett Rumery, co-founder and CEO of Perfect Paw. Pietro Kabeya, FareVet's founder and CEO, framed the value in workflow terms: "When a dog sees a new vet through FareVet, that vet isn't starting from scratch."

Neither company disclosed financial terms of the partnership.

Why It Matters

The partnership itself is modest in scale. Two early-stage startups, neither of which has disclosed institutional funding, are connecting their respective platforms. But the integration model deserves attention for three reasons.

1. The "data-before-visit" model is where vet tech is heading. Veterinary medicine has historically operated on episodic, in-clinic data collection. The owner describes symptoms, the vet examines the animal, and treatment decisions follow from that snapshot. Continuous monitoring inverts that model. When a clinician can review days or weeks of biometric data before an appointment, the visit shifts from diagnostic discovery to treatment planning. That's a fundamentally different workflow, and it's one that established players are already building toward. PetPace, which launched its 2.0 AI-driven collar in 2024, has positioned its device explicitly for veterinary research and clinical use. Mars Petcare's Whistle Labs has GPS and activity tracking embedded in a portfolio that connects to Banfield's clinic network. FareVet and Perfect Paw are smaller operators pursuing the same structural idea.

2. Pain detection is the highest-value clinical application for pet wearables. The pet wearable market is projected to reach $4.7 billion by 2026, growing at roughly 14% annually. But most consumer wearables today focus on activity tracking and GPS, features that serve pet owners but offer limited clinical utility. Pain detection changes the equation. Dogs mask discomfort instinctively, making pain one of the hardest things for owners and vets to assess accurately. If a wearable can reliably flag pain signals between visits, it becomes a clinical tool, not just a consumer gadget. That distinction matters for distribution. Veterinary hospitals and clinics are the fastest-growing end-user segment for smart collars, expanding at roughly 15% annually. Clinical utility drives clinic adoption, which drives recurring device attachment.

3. The real question is data standards. Right now, every pet wearable company builds its own data format, its own AI models, its own clinical dashboards. There is no interoperability. FareVet's integration with Perfect Paw works because two companies agreed to connect their systems. But for this model to scale across the industry, veterinary practice management software (Shepherd, eVetPractice, Covetrus) would need to ingest wearable data as a standard data type, the way human health systems now accept data from Apple Watch or Fitbit through HL7 FHIR standards. That infrastructure doesn't exist yet in veterinary medicine. Whoever builds it, or builds the integrations that approximate it, has a meaningful competitive advantage.

What to Watch

Perfect Paw's clinical validation. Pain detection claims need published data to earn veterinary trust. PetPace has invested in peer-reviewed research to validate its monitoring capabilities. Perfect Paw will need similar evidence for The Ruff's AI engine to move beyond early adopters.

FareVet's network scale. The value of this integration scales directly with the number of clinics on FareVet's platform. If FareVet remains a niche price-comparison tool, the data pipeline reaches few practitioners. If it grows into a broader veterinary marketplace, the integration becomes more significant.

Practice management software moves. Watch for Covetrus (now part of IDEXX), Shepherd, and other veterinary software platforms to announce wearable data integrations of their own. When the practice management layer starts accepting continuous monitoring data natively, that's the inflection point for this category.

Incumbent response. Mars Petcare already owns both Whistle (wearables) and Banfield/VCA (clinics). The vertical integration play is obvious. Whether Mars connects those assets into a data-before-visit workflow, or whether startups like FareVet and Perfect Paw build the interoperable alternative, will shape how this market develops.

Related Analysis

• Loyal Raises $100M to Bring the First Canine Longevity Drug to Market

Source: FareVet Partners With Perfect Paw to Bring Real-Time Canine Pain Intelligence to Veterinary Care via LinkedIn

‍